Kiniksa Pharmaceuticals International KNSA Balance Sheet (2017-2026)

NASDAQ KNSA
$79.23 +2.14 (+2.78%)
As of: Sep 9, 2026 · 2:47 PM EDT
Reported Financials

Kiniksa Pharmaceuticals International Quarterly Balance Sheet

Periods 35 quarters
Latest Jun 2026

Kiniksa Pharmaceuticals International reported total assets of $896.11M and total liabilities of $241.96M for the quarter ended Jun 2026, up 35.5% year over year. This balance sheet covers 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
200.18M122.47M145.58M138.21M200.72M122.72M187.49M184.99M201.08M107.95M213.55M218.76M223.78M183.58M268.34M307.78M352.10M165.60M189.95M175.68M
Short-term InvestmentsInvestments (Current)
10.00M59.73M67.89M72.42M83.26M98.42M72.47M119.49M126.40M60.05M111.21M115.75M177.24M248.48M278.14M350.25M
Cash & Current Investments
210.18M182.20M145.58M138.21M200.72M190.61M187.49M257.42M284.34M206.37M286.03M338.25M350.18M243.63M379.55M423.53M529.35M414.07M468.09M525.93M
Receivables - NetNet Receivables
3.22M3.98M29.44M7.81M11.16M12.66M7.42M24.65M3.04M21.27M15.99M20.45M24.89M41.72M40.06M31.91M51.74M15.59M23.22M23.49M
Receivables - OtherOther Receivables
7.66M
Receivables
3.22M3.98M29.44M7.81M11.16M20.32M7.42M24.65M3.04M21.27M15.99M20.45M24.89M41.72M40.06M31.91M51.74M15.59M23.22M23.49M
Work In Process
4.18M0.15M6.31M13.52M6.62M13.38M18.26M
Finished Goods
1.42M3.67M13.07M19.92M14.62M15.29M9.91M17.34M12.20M12.86M
Inventory
5.61M3.67M13.22M19.92M14.62M21.60M23.43M23.96M25.58M31.12M27.28M34.86M28.68M26.36M22.07M48.18M41.40M54.90M73.14M70.93M
Prepaid Assets
8.50M6.58M10.52M14.01M15.31M10.54M13.16M12.44M26.40M17.54M13.77M26.95M33.95M20.08M25.43M32.44M30.29M42.61M29.71M48.28M
Current Assets
217.51M196.45M198.76M179.94M241.81M243.06M231.50M246.04M256.11M276.30M270.59M301.02M311.30M331.80M355.91M420.31M475.53M527.18M594.17M668.63M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
3.17M2.83M2.48M2.15M2.00M1.66M1.39M1.14M0.92M0.73M0.71M0.62M0.56M0.66M0.61M1.08M1.66M1.94M1.99M2.58M
Intangibles
20.00M20.00M20.00M20.00M20.00M20.00M20.00M20.00M17.50M20.00M17.00M16.75M16.50M20.00M16.00M15.75M15.50M15.25M15.00M14.75M
Goodwill & Intangibles
20.00M20.00M20.00M20.00M20.00M20.00M20.00M20.00M17.50M20.00M17.00M16.75M16.50M20.00M16.00M15.75M15.50M15.25M15.00M14.75M
Long-Term Deferred Tax
185.84M185.50M184.42M203.86M193.57M219.28M214.92M204.35M207.99M211.15M208.16M205.51M201.29M198.15M193.63M190.97M
Other Non-Current Assets
6.55M8.72M5.92M5.67M5.63M5.82M2.32M2.35M2.29M0.83M4.13M7.90M7.85M10.31M8.20M8.20M8.29M11.31M11.16M10.83M
Non-Current Assets
35.35M36.35M32.21M30.64M218.14M216.61M211.36M238.29M226.95M250.03M249.08M241.41M244.00M248.75M243.42M240.84M236.80M236.46M231.11M227.48M
Assets
252.86M232.80M230.97M210.58M459.95M459.67M442.86M484.33M483.06M526.32M519.67M542.43M555.30M580.55M599.33M661.15M712.33M763.63M825.28M896.11M
Liabilities
Current Liabilities
Accounts Payables
1.65M1.87M3.38M2.52M1.47M7.90M1.39M0.65M1.01M8.25M5.63M7.39M8.33M2.04M1.98M8.96M6.15M2.03M24.40M12.40M
Payables
1.65M1.87M3.38M2.52M1.47M7.90M1.39M0.65M1.01M8.25M5.63M7.39M8.33M2.04M1.98M8.96M6.15M2.03M24.40M12.40M
Accumulated Expenses
28.53M38.03M38.89M34.50M30.87M30.11M20.89M35.32M41.15M27.73M44.72M33.37M40.38M32.35M22.13M35.96M30.94M42.02M32.77M46.73M
Other Accumulated Expenses
17.80M24.98M22.21M14.37M13.56M8.38M4.33M7.71M8.41M8.19M11.43M11.48M16.07M17.05M17.09M18.00M20.52M22.13M20.69M20.05M
Current Leases
3.25M3.38M3.31M3.34M3.27M3.30M3.48M2.24M2.31M2.25M2.28M2.08M2.03M1.99M2.29M2.52M2.70M2.99M3.17M4.01M
Current Deferred Revenue
26.29M12.00M6.50M4.67M2.56M12.26M0.16M0.01M31.81M
Total Current Liabilities
34.43M44.82M50.35M43.54M56.49M47.07M36.59M47.47M53.47M63.67M64.21M84.29M95.95M100.62M97.27M117.83M123.59M139.18M156.61M171.25M
Non-Current Liabilities
Non-Current Deffered Revenue
12.00M12.00M14.20M12.00M12.16M12.01M11.87M11.95M11.81M11.80M11.81M31.81M31.81M31.81M31.81M31.81M31.81M31.81M
Preferred Stock Liabilities
Operating Leases
3.50M2.67M2.10M1.28M3.44M2.62M2.13M11.28M10.65M10.01M9.86M9.32M8.56M7.86M7.62M7.24M7.02M6.51M5.86M4.88M
Other Non-Current Liabilities
0.89M0.27M0.27M0.26M1.82M1.84M1.88M1.92M1.95M1.86M1.89M1.93M1.96M1.82M5.14M9.26M14.53M18.52M25.32M34.02M
Total Non-Current Liabilities
37.93M47.49M64.45M56.82M74.12M61.68M50.88M70.76M75.99M85.62M85.89M105.41M116.33M140.29M136.70M156.88M162.43M177.50M194.28M207.94M
Total Liabilities
38.81M47.76M64.72M57.08M75.94M63.52M52.77M72.68M77.94M87.48M87.78M107.33M118.29M142.12M141.84M166.14M176.95M196.03M219.59M241.96M
Shareholder's Equity
Common Equity
214.05M185.04M166.24M153.49M384.01M396.15M390.10M411.66M405.13M438.84M431.89M435.10M437.01M438.44M457.49M495.01M535.38M567.61M605.69M654.15M
Liabilities and Shareholders Equity
252.86M232.80M230.97M210.58M459.95M459.67M442.86M484.33M483.06M526.32M519.67M542.43M555.30M580.55M599.33M661.15M712.33M763.63M825.28M896.11M
Retained Earnings
853.14M860.48M866.93M874.15M880.55M888.12M894.33M900.96M908.29M916.76M927.58M934.77M949.28M959.72M970.24M989.81M1,011.85M1,029.75M1,045.88M1,069.62M
Treasury Shares